Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × dacomitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Neoplasm Metastasis 6 Lung Neoplasms 4 Recurrence 3 Carcinoma, Squamous Cell 3 Brain Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 NSCLC 2 Head and Neck Neoplasms 2 Glioblastoma 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Rare Tumor 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Fluorouracil 422 Bevacizumab 395 Oxaliplatin 375 Leucovorin 370 Irinotecan 345 Capecitabine 271 Cetuximab 270 pembrolizumab 122 Folfox protocol 110 Panitumumab 96 regorafenib 92 Colonoscopy 73 IFL protocol 72 Drug Therapy 67 Nivolumab 65 trifluridine tipiracil drug combination 60 Radiotherapy 59 HMPL-013 52 Blood Specimen Collection 49 Gemcitabine 43 Neoadjuvant Therapy 42 Specimen Handling 40 Chemotherapy, Adjuvant 38 Cyclophosphamide 37 Biopsy 37 Standard of Care 36 Surveys and Questionnaires 34 atezolizumab 33 Magnetic Resonance Spectroscopy 33 Trifluridine 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02039336 2025-07-08

M13DAP

The Netherlands Cancer Institute

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡